CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Lutetium psma therapy
PROSTATE-SPECIFIC MEMBRANE ANTIGEN THERAPY USING LUTETIUM-177 (LU-177)
PSMA therapy may be a useful treatment option for you if you have prostate cancer that is no longer controlled by other standard treatments
What is Lutetium PSMA therapy?
Lutetium PSMA (Prostate Specific Membrane Antigen), first conducted in 2019 at the Hybrid Imaging & Therapy Unit at The Wellington Hospital, is a new treatment for advanced prostate cancer that has spread beyond the prostate gland and is resistant to other treatments. Lutetium PSMA aims to control the disease, improve your symptoms and help you live longer.
The Hybrid Imaging & Therapy Unit offers an integrated prostate cancer PSMA PET diagnostic and Lu-177 PSMA therapy service, whereby our team of nuclear medicine doctors and oncologists at The Prostate Centre work in collaboration to ensure that you are carefully monitored before, during and after your Lutetium-177 PSMA treatment. Whether you are suitable for this treatment is carefully deliberated at our multidisciplinary team meetings (MDTs).
Need to know
Lutetium PSMA treatment will be administered at The Wellington Hospital by our highly skilled multi-professional team at the Nuclear Medicine Hybrid Imaging and Therapy Unit, who work closely with your oncologist, to deliver the best care for you.
Treatment is usually given as a day-case procedure although some people prefer to stay in overnight afterwards. You will have between four and six treatments at 6 to 8 week intervals.
PSMA therapy is given as a drip into a vein in your hand or arm. It takes about 20 minutes and has no immediate side effects. We will ask you to drink plenty of water before and afterwards.
Our nuclear medicine therapy consultant will explain the procedure to you and answer any questions you may have. Because Lutetium PSMA is a radioactive medicine, we will ask you to follow some straightforward safety precautions after your treatment.
You should expect to feel a bit more tired than usual for a week after your PSMA treatment. Your oncologist will see you and arrange a follow up blood test roughly 4 weeks after each PSMA therapy. Some people find that they have a dry mouth or eyes afterwards but this usually settles once the whole course of PSMA treatment is completed.
Lutetium psma therapy Consultants
Dr. Nicola Mulholland
Radiology
Professor Sotirios Bisdas
Radiology
Dr Dimitri Amiras
Radiology
Dr Shaunak Navalkissoor
Nuclear Medicine
Our Lutetium psma therapy locations
The Prostate Centre
18 Devonshire Street W1G 7AQ London
The Wellington Hospital
8A Wellington Place NW8 9LE London
Patient stories
Yvette's story: From back pain to hip replacement surgery
Yvette (54) a journalist from Kent, started experiencing pain in her hip seven years ago in 2015. An ex-national gymnast who had been incredibly active and flexible her whole life, Yvette felt concerned about the growing discomfort impacting her quality of life, and so sought help from her GP.
A new hip and straight back into the spin of things
Michael's MAKO hip surgery to treat his arthritis
73 year-old Michael, an avid walker and charity worker, was diagnosed with arthritis in January 2021. After facing long waiting times and increasing pain that was becoming more frequent, he started to look elsewhere for treatment.
This content is intended for general information only and does not replace the need for personal advice from a qualified health professional.